Travere Therapeutics Inc (TVTX)
R&D Expenses
$60.28M
Quarterly · Period ending: · USD
TVTX R&D Expenses
Latest reported$60.28Mperiod ending
Latest reported$60.28Mperiod ending
TVTX Quarterly R&D Expenses ($0.00 → $60.28M)
Quarterly R&D Expenses
High-resolution chart · PNG
TVTX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 60,283,000 | |
| 57,094,000 | |
| 57,870,000 | |
| 51,890,000 | |
| 49,362,000 | |
| 46,889,000 | |
| 62,067,000 | |
| 51,679,000 | |
| 54,330,000 | |
| 114,625,000 | |
| 58,749,000 | |
| 60,590,000 | |
| 66,492,000 | |
| 59,913,000 | |
| 60,232,000 | |
| 57,145,000 | |
| 59,681,000 | |
| 56,611,000 | |
| 62,168,000 | |
| 48,407,000 | |
| 51,807,000 | |
| 47,946,000 | |
| 38,386,000 | |
| 32,349,000 | |
| 30,790,000 | |
| 30,249,000 | |
| 36,074,000 | |
| 33,220,000 | |
| 37,934,000 | |
| 33,443,000 | |
| 31,995,000 | |
| 32,448,000 | |
| 34,460,000 | |
| 24,636,000 | |
| 19,576,000 | |
| 19,610,000 | |
| 19,482,000 | |
| 20,860,000 | |
| 20,078,000 | |
| 18,428,000 | |
| 17,675,000 | |
| 14,672,000 | |
| 15,452,000 | |
| 14,064,000 | |
| 10,563,000 | |
| 10,346,456 | |
| 14,191,777 | |
| 13,018,729 | |
| 13,697,991 | |
| 6,886,726 | |
| 4,970,196 | |
| 1,399,875 | |
| 605,203 | |
| 158,690 | |
| 375,613 | |
| 110,656 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |